Image pharmaphorum Editor R&D Can technology help diversify clinical trials? This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. R&D Why are clinical trials struggling with diversity? In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative. Sales & Marketing Next generation coaching Capturing an audience is a critical task. Doing that in a wind tunnel of multi-channel white noise requires a special brand of cut-through. Patients Taking patient engagement efforts beyond box-ticking Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do. Load more results
R&D Can technology help diversify clinical trials? This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials.
R&D Why are clinical trials struggling with diversity? In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative.
Sales & Marketing Next generation coaching Capturing an audience is a critical task. Doing that in a wind tunnel of multi-channel white noise requires a special brand of cut-through.
Patients Taking patient engagement efforts beyond box-ticking Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
